49 computer-programmer-"St"-"FEMTO-ST"-"University-of-St"-"St" positions at Nature Careers in Canada
Sort by
Refine Your Search
-
that maintain homeostasis, with a focus on aging. Research Focus and Expertise We are seeking an early career scientist with demonstrated potential to establish a robust, externally funded research program. The
-
evidence of prior funding A research statement highlighting the proposed research program (not exceeding 3 pages, including figures; references can be on a separate page) A statement (0.5 to 1 page
-
program. Position Summary The MacDonald Lab (www.bcell.org) at the Alberta Diabetes Institute would like to hear from postdoctoral candidates with a keen interest in advancing understanding of insulin and
-
Program research grant, this project brings together complementary expertise of the Zhulyn (Canada), Lagha (France), vanOudenaarden (Netherlands) and Kelleher (US) labs for a team-driven, multidisciplinary
-
of the research plan A research statement highlighting the proposed research program (not exceeding 3 pages, including figures; references can be on a separate page) A statement (0.5 to 1 page) highlighting past
-
Nature Careers | Victoria Central British Columbia Provincial Government, British Columbia | Canada | 3 months ago
5–10 years. The appointee will be expected to establish an independent, creative, innovative, high-impact, and externally funded research program. The proposed research program should have the
-
to provide expert scientific guidance and hands-on support for our R&D team. As we rapidly advance our novel cell therapy program for oncology, your deep expertise in immunology, T-cell biology, and cancer
-
Nature Careers | Regina South Saskatchewan Provincial Government, Saskatchewan | Canada | about 2 months ago
Area, consistent with the strategic plan and mission of the SHA. The Area Chief of Staff will be appointed to the Practitioner Staff of the SHA, will hold a faculty appointment with the College
-
in preclinical testing. The core technology has FDA approval for Phase I trials, but needs optimization on the I.P., scale manufacture and antigen production areas. Our plan is to leverage emerging